Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
PositiveFinancial Markets

Eli Lilly has announced a significant investment of over $1 billion in India to enhance its manufacturing capacity. This move is crucial as it not only strengthens the company's presence in one of the world's fastest-growing pharmaceutical markets but also contributes to local job creation and economic growth. By expanding its operations, Eli Lilly aims to meet the increasing demand for its products while ensuring a robust supply chain, which is vital in today's healthcare landscape.
— Curated by the World Pulse Now AI Editorial System